Robert S. Goodenow

1.5k total citations
37 papers, 1.3k citations indexed

About

Robert S. Goodenow is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Robert S. Goodenow has authored 37 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 18 papers in Molecular Biology and 11 papers in Genetics. Recurrent topics in Robert S. Goodenow's work include Immunotherapy and Immune Responses (12 papers), T-cell and B-cell Immunology (11 papers) and Virus-based gene therapy research (8 papers). Robert S. Goodenow is often cited by papers focused on Immunotherapy and Immune Responses (12 papers), T-cell and B-cell Immunology (11 papers) and Virus-based gene therapy research (8 papers). Robert S. Goodenow collaborates with scholars based in United States, United Kingdom and Israel. Robert S. Goodenow's co-authors include Leroy Hood, Julie M. Vogel, R Linsk, Minnie McMillan, Norman Davidson, Margery Nicolson, Anders Örn, Beverly Taylor Sher, Kurt A. Eakle and Christopher J. Wheeler and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Robert S. Goodenow

37 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert S. Goodenow United States 23 837 519 285 252 187 37 1.3k
C T Wake United States 17 1.1k 1.3× 810 1.6× 416 1.5× 334 1.3× 196 1.0× 18 2.0k
G. M. Fulop Canada 14 808 1.0× 553 1.1× 196 0.7× 159 0.6× 300 1.6× 24 1.4k
P W Tucker United States 22 851 1.0× 865 1.7× 558 2.0× 141 0.6× 141 0.8× 44 1.6k
H. Pritchard-Briscoe Australia 9 1.6k 1.9× 267 0.5× 401 1.4× 241 1.0× 134 0.7× 12 1.8k
Judy Kantor United States 23 1.0k 1.2× 686 1.3× 239 0.8× 481 1.9× 488 2.6× 31 1.6k
John S. Wotherspoon Australia 11 1.4k 1.7× 290 0.6× 362 1.3× 183 0.7× 147 0.8× 16 1.7k
Sjef Verbeek Netherlands 13 1.2k 1.5× 905 1.7× 330 1.2× 192 0.8× 423 2.3× 14 2.2k
Pamela Hamlyn United Kingdom 15 390 0.5× 931 1.8× 393 1.4× 193 0.8× 222 1.2× 20 1.5k
Jeannine Trucy France 18 1.7k 2.0× 420 0.8× 360 1.3× 112 0.4× 401 2.1× 24 1.9k
Wesley A. Dunnick United States 24 1.2k 1.4× 1.0k 2.0× 487 1.7× 138 0.5× 219 1.2× 57 1.9k

Countries citing papers authored by Robert S. Goodenow

Since Specialization
Citations

This map shows the geographic impact of Robert S. Goodenow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert S. Goodenow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert S. Goodenow more than expected).

Fields of papers citing papers by Robert S. Goodenow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert S. Goodenow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert S. Goodenow. The network helps show where Robert S. Goodenow may publish in the future.

Co-authorship network of co-authors of Robert S. Goodenow

This figure shows the co-authorship network connecting the top 25 collaborators of Robert S. Goodenow. A scholar is included among the top collaborators of Robert S. Goodenow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert S. Goodenow. Robert S. Goodenow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gelber, Cohava, Lea Eisenbach, Michael B. Feldman, & Robert S. Goodenow. (1991). T-cell subset analysis of 3LL tumor growth. International Journal of Cancer. 47(S6). 69–72. 1 indexed citations
2.
Kuhner, Mary K., et al.. (1990). Gene conversion in the evolution of both the H-2 and Qa class I genes of the murine major histocompatibility complex.. Genetics. 126(4). 1115–1126. 14 indexed citations
3.
Vogel, Julie M., et al.. (1990). Overlapping palindromic sequences associated with somatic deletion and meiotic recombination of MHC class I genes. Molecular Immunology. 27(9). 875–886. 8 indexed citations
4.
Liegler, Teri, et al.. (1990). An analysis of insulin receptor expression and binding on MHC class I positive and negative human lymphoblastoid cells.. The Journal of Immunology. 145(6). 1788–1793. 4 indexed citations
5.
Davis, Ann C., et al.. (1989). Sequence analysis of the C3H H-2K1 k gene: relationship to the H-2 loci. Immunogenetics. 29(5). 355–357. 10 indexed citations
6.
Vogel, Julie M., et al.. (1989). A novel H-2K splice form: predictions for other alternative H-2 splicing events. Immunogenetics. 29(1). 33–43. 7 indexed citations
7.
Wheeler, Christopher J., et al.. (1989). Amino acid comparison of the class I antigens of mouse major histocompatibility complex. Immunogenetics. 30(5). 390–392. 40 indexed citations
8.
Kuhner, Mary K. & Robert S. Goodenow. (1989). DNA sequences of mouseH-2 andQa genes. Immunogenetics. 30(6). 458–464. 23 indexed citations
9.
Linsk, R, et al.. (1989). The tumor-rejection antigens of the 1591 ultraviolet fibrosarcoma. Potential origin and evolutionary implications.. The Journal of Experimental Medicine. 169(3). 1043–1058. 7 indexed citations
10.
Vogel, Julie M., Ann C. Davis, Denise M. McKinney, et al.. (1988). Molecular characterization of the C3HfB/HeN H-2Kkm2 mutation. Implications for the molecular basis of alloreactivity.. The Journal of Experimental Medicine. 168(5). 1781–1800. 26 indexed citations
11.
Song, Elizabeth S., R Linsk, C A Olson, M. McMillan, & Robert S. Goodenow. (1988). Allospecific cytotoxic T lymphocytes recognize an H-2 peptide in the context of a murine major histocompatibility complex class I molecule.. Proceedings of the National Academy of Sciences. 85(6). 1927–1931. 54 indexed citations
12.
Linsk, R, Julie M. Vogel, Hans J. Stauss, James Forman, & Robert S. Goodenow. (1986). Structure and function of three novel MHC class I antigens derived from a C3H ultraviolet-induced fibrosarcoma.. The Journal of Experimental Medicine. 164(3). 794–813. 41 indexed citations
13.
Goodenow, Robert S., et al.. (1985). Molecular basis of the dm1 mutation in the major histocompatibility complex of the mouse: a D/L hybrid gene.. The Journal of Experimental Medicine. 162(5). 1588–1602. 57 indexed citations
14.
Stroynowski, Iwona, James Forman, Robert S. Goodenow, et al.. (1985). Expression and T cell recognition of hybrid antigens with amino-terminal domains encoded by Qa-2 region of major histocompatibility complex and carboxyl termini of transplantation antigens.. The Journal of Experimental Medicine. 161(5). 935–952. 37 indexed citations
15.
Goodenow, Robert S., Julie M. Vogel, & R Linsk. (1985). Histocompatibility Antigens on Murine Tumors. Science. 230(4727). 777–783. 137 indexed citations
16.
Forman, J, Robert S. Goodenow, Leroy Hood, & Richard P. Ciavarra. (1983). Use of DNA-mediated gene transfer to analyze the role of H-2Ld in controlling the specificity of anti-vesicular stomatitis virus cytotoxic T cells.. The Journal of Experimental Medicine. 157(4). 1261–1272. 24 indexed citations
17.
Örn, Anders, Robert S. Goodenow, Leroy Hood, et al.. (1982). Product of a transferred H–2Ld gene acts as restriction element for LCMV-specific killer T cells. Nature. 297(5865). 415–417. 59 indexed citations
18.
Goodenow, Robert S., Minnie McMillan, Anders Örn, et al.. (1982). Identification of a BALB/c H-2L d Gene by DNA-Mediated Gene Transfer. Science. 215(4533). 677–679. 86 indexed citations
19.
Kaplan, H S, Robert S. Goodenow, Suzanne Gartner, & Marcia M. Bieber. (1979). Biology and virology of the human malignant lymphomas.1st Milford D. Schulz lecture. Cancer. 43(1). 1–24. 27 indexed citations
20.
Goodenow, Robert S. & Henry S. Kaplan. (1979). Characterization of the reverse transcriptase of a type C RNA virus produced by a human lymphoma cell line. Proceedings of the National Academy of Sciences. 76(10). 4971–4975. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C T Wake Breakdown of academic impact, for papers by G. M. Fulop Breakdown of academic impact, for papers by P W Tucker Breakdown of academic impact, for papers by H. Pritchard-Briscoe Breakdown of academic impact, for papers by Judy Kantor Breakdown of academic impact, for papers by John S. Wotherspoon Breakdown of academic impact, for papers by Sjef Verbeek Breakdown of academic impact, for papers by Pamela Hamlyn Breakdown of academic impact, for papers by Jeannine Trucy Breakdown of academic impact, for papers by Wesley A. Dunnick
Rankless by CCL
2026